
Brand Name | Status | Last Update |
|---|---|---|
| detectnet | New Drug Application | 2025-01-31 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 2 | 2 | 2 | 1 | 3 | 10 |
| Neoplasms | D009369 | — | C80 | 1 | — | — | 1 | 1 | 3 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | — | 1 | 1 | 2 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | — | 1 | 1 | 2 |
| Intestinal neoplasms | D007414 | — | C26.0 | — | — | — | 1 | 1 | 2 |
| Islet cell adenoma | D007516 | EFO_0007331 | D13.7 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pheochromocytoma | D010673 | — | — | — | 1 | — | — | 1 | 2 |
| Paraganglioma | D010235 | — | — | — | 1 | — | — | 1 | 2 |
| Neuroendocrine carcinoma | D018278 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sarcoidosis | D012507 | EFO_0000690 | D80-D89 | — | — | — | — | 2 | 2 |
| Gastrointestinal neoplasms | D005770 | — | C26.9 | — | — | — | — | 1 | 1 |
| Digestive system neoplasms | D004067 | — | — | — | — | — | — | 1 | 1 |
| Gastrointestinal diseases | D005767 | — | — | — | — | — | — | 1 | 1 |
| Germ cell and embryonal neoplasms | D009373 | — | — | — | — | — | — | 1 | 1 |
| Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | — | — | — | — | 1 | 1 |
| Neoplasms by histologic type | D009370 | — | — | — | — | — | — | 1 | 1 |
| Endocrine gland neoplasms | D004701 | EFO_0003769 | D35 | — | — | — | — | 1 | 1 |
| Neoplasms by site | D009371 | — | — | — | — | — | — | 1 | 1 |
| Nerve tissue neoplasms | D009380 | — | — | — | — | — | — | 1 | 1 |
| Drug common name | Copper oxodotreotide cu-64 |
| INN | _ |
| Description | Copper oxodotreotide cu-64 is a protein pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Protein |
| Drug class | peptides: inhibition of growth hormone release |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL4297339 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | N3858377KC (ChemIDplus, GSRS) |

